Log in

Dr.Reddy's Laboratories News Headlines (NYSE:RDY)

$45.45
-0.40 (-0.87 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$45.27
Now: $45.45
$46.01
50-Day Range
$40.04
MA: $42.45
$45.85
52-Week Range
$34.67
Now: $45.45
$46.19
Volume277,841 shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio32.23
Dividend YieldN/A
BetaN/A

Headlines

Dr.Reddy's Laboratories (NYSE RDY) News Headlines

Source:
DateHeadline
Dr.Reddys Laboratories (NYSE:RDY) Receiving Somewhat Negative Press Coverage, Analysis ShowsDr.Reddy's Laboratories (NYSE:RDY) Receiving Somewhat Negative Press Coverage, Analysis Shows
www.americanbankingnews.com - February 14 at 9:31 AM
Dr. Reddy’s Laboratories to Acquire Select Business Divisions of Wockhardt in IndiaDr. Reddy’s Laboratories to Acquire Select Business Divisions of Wockhardt in India
www.businesswire.com - February 12 at 9:51 AM
Dr. Reddys Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market
www.businesswire.com - February 7 at 8:17 AM
Dr. Reddy's Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Trientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market
finance.yahoo.com - February 7 at 8:17 AM
Dr. Reddys Laboratories and Its U.S. Subsidiary, Promius Pharma, Announce FDA Approval for TOSYMRA™ (Sumatriptan Nasal Spray)Dr. Reddy's Laboratories and Its U.S. Subsidiary, Promius Pharma, Announce FDA Approval for TOSYMRA™ (Sumatriptan Nasal Spray)
www.bloomberg.com - February 7 at 12:03 AM
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170
finance.yahoo.com - February 6 at 9:02 AM
Dr.Reddys Laboratories Ltd (NYSE:RDY) Receives Average Recommendation of "Hold" from AnalystsDr.Reddy's Laboratories Ltd (NYSE:RDY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 4 at 8:01 PM
FY2020 Earnings Estimate for Dr.Reddys Laboratories Ltd Issued By Jefferies Financial Group (NYSE:RDY)FY2020 Earnings Estimate for Dr.Reddy's Laboratories Ltd Issued By Jefferies Financial Group (NYSE:RDY)
www.americanbankingnews.com - January 30 at 12:49 PM
Dr. Reddy’s Laboratories swings to net loss in third quarterDr. Reddy’s Laboratories swings to net loss in third quarter
finance.yahoo.com - January 27 at 8:41 AM
Dr. Reddy’s Q3 & 9M FY20 Financial ResultsDr. Reddy’s Q3 & 9M FY20 Financial Results
finance.yahoo.com - January 27 at 8:41 AM
Dr. Reddys Laboratories Announces the Launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market
finance.yahoo.com - December 30 at 9:22 AM
Dr. Reddy's Laboratories Announces the Launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market
finance.yahoo.com - December 30 at 9:22 AM
Hedge Funds Are Piling Into Dr. Reddy’s Laboratories Limited  (RDY)Hedge Funds Are Piling Into Dr. Reddy’s Laboratories Limited (RDY)
finance.yahoo.com - December 13 at 2:20 PM
Dr. Reddys Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market
www.businesswire.com - December 6 at 8:39 AM
Dr. Reddy's Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market
finance.yahoo.com - December 6 at 8:39 AM
Dr. Reddy's Laboratories Announces the Launch of Deferasirox Tablets for Oral Suspension, in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Deferasirox Tablets for Oral Suspension, in the U.S. Market
finance.yahoo.com - December 6 at 8:39 AM
Dr. Reddys Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market
finance.yahoo.com - December 4 at 8:29 AM
Dr. Reddys Laboratories announces launch of Doxercalciferol Injection in the U.S. MarketDr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market
finance.yahoo.com - November 22 at 9:14 AM
Dr. Reddy’s Q2 & H1 FY20 Financial ResultsDr. Reddy’s Q2 & H1 FY20 Financial Results
finance.yahoo.com - November 1 at 9:03 AM
Hedge Fund Sentiment Unchanged On Dr. Reddy’s Laboratories Limited (RDY)Hedge Fund Sentiment Unchanged On Dr. Reddy’s Laboratories Limited (RDY)
finance.yahoo.com - October 17 at 6:41 PM
Dr. Reddys to release Q2 FY 20 results on November 1, 2019Dr. Reddy's to release Q2 FY 20 results on November 1, 2019
finance.yahoo.com - October 14 at 7:18 AM
Mylan (MYL) to Pay $30M to Settle SEC Charges for EpiPenMylan (MYL) to Pay $30M to Settle SEC Charges for EpiPen
finance.yahoo.com - September 30 at 8:55 PM
BridgeBio Pharma (BBIO) Jumps: Stock Rises 7.1%BridgeBio Pharma (BBIO) Jumps: Stock Rises 7.1%
finance.yahoo.com - September 23 at 1:16 PM
The Zacks Analyst Blog Highlights: Dr. Reddy's, WNS and Azure PowerThe Zacks Analyst Blog Highlights: Dr. Reddy's, WNS and Azure Power
finance.yahoo.com - September 23 at 1:16 PM
Dr. Reddys Laboratories Announces the Launch of Fosaprepitant for Injection in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Fosaprepitant for Injection in the U.S. Market
finance.yahoo.com - September 12 at 8:02 AM
Dr. Reddys Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare ConferenceDr. Reddy's Laboratories Limited to Present at the Morgan Stanley Annual Global Healthcare Conference
finance.yahoo.com - September 6 at 5:09 PM
Dr. Reddys Laboratories announces the launch of Versavo® (bevacizumab biosimilar) in IndiaDr. Reddy's Laboratories announces the launch of Versavo® (bevacizumab biosimilar) in India
finance.yahoo.com - August 19 at 9:12 AM
Exelixis and Aurigene Enter Into Exclusive Collaboration, Option and License Agreement to Discover and Develop Novel Therapies for CancerExelixis and Aurigene Enter Into Exclusive Collaboration, Option and License Agreement to Discover and Develop Novel Therapies for Cancer
finance.yahoo.com - July 31 at 7:16 PM
Dr. Reddys Laboratories announces the launch of Pregabalin Capsules in the U.S. MarketDr. Reddy's Laboratories announces the launch of Pregabalin Capsules in the U.S. Market
finance.yahoo.com - July 30 at 7:04 PM
Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/YDr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y
finance.yahoo.com - July 30 at 7:04 PM
Dr. Reddy’s Q1 FY20 Financial ResultsDr. Reddy’s Q1 FY20 Financial Results
finance.yahoo.com - July 29 at 9:42 AM
Dr. Reddys Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market
finance.yahoo.com - July 23 at 10:48 AM
Indivior loses appeal to block generic Suboxone opioid treatmentsIndivior loses appeal to block generic Suboxone opioid treatments
finance.yahoo.com - July 13 at 10:24 AM
Dr. Reddys to release Q1 FY 20 results on July 29, 2019Dr. Reddy's to release Q1 FY 20 results on July 29, 2019
finance.yahoo.com - July 10 at 9:13 AM
Dr. Reddys Laboratories Announces First-to-market Launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial in the U.S. MarketDr. Reddy's Laboratories Announces First-to-market Launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial in the U.S. Market
finance.yahoo.com - July 3 at 9:17 AM
Here’s What Hedge Funds Think About Dr. Reddy’s Laboratories Limited  (RDY)Here’s What Hedge Funds Think About Dr. Reddy’s Laboratories Limited (RDY)
finance.yahoo.com - June 28 at 5:45 PM
Dr. Reddys Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. Market
finance.yahoo.com - June 25 at 10:45 AM
Dr. Reddys Laboratories Announces the Launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the U.S. Market
finance.yahoo.com - June 22 at 9:14 AM
Dr. Reddys Laboratories Limited Through Its Wholly Owned Subsidiary, Dr. Reddy’s Laboratories SA, Announces Positive Topline Results from Phase 2b Study of PPC-06 in Patients with Moderate to Severe Plaque PsoriasisDr. Reddy's Laboratories Limited Through Its Wholly Owned Subsidiary, Dr. Reddy’s Laboratories SA, Announces Positive Topline Results from Phase 2b Study of PPC-06 in Patients with Moderate to Severe Plaque Psoriasis
finance.yahoo.com - June 10 at 9:53 AM
Dr. Reddys Laboratories Announces the Re-Launch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg in the U.S. MarketDr. Reddy's Laboratories Announces the Re-Launch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg in the U.S. Market
finance.yahoo.com - June 3 at 6:07 PM
Dr. Reddy's (RDY) Q4 Earnings Up Y/Y, Revenues Top EstimatesDr. Reddy's (RDY) Q4 Earnings Up Y/Y, Revenues Top Estimates
finance.yahoo.com - May 20 at 7:55 PM
Dr. Reddy’s Q4 & FY19 Financial ResultsDr. Reddy’s Q4 & FY19 Financial Results
finance.yahoo.com - May 17 at 6:59 PM
Dr. Reddy's (RDY) Earnings Rise in Q4, Revenues BeatDr. Reddy's (RDY) Earnings Rise in Q4, Revenues Beat
finance.yahoo.com - May 17 at 9:10 AM
Dr. Reddys Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. MarketDr. Reddy's Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market
finance.yahoo.com - May 15 at 9:18 AM
Dr. Reddys Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. MarketDr. Reddy's Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market
finance.yahoo.com - May 6 at 9:15 AM
Here’s What Hedge Funds Think About Dr. Reddy’s Laboratories Limited (RDY)Here’s What Hedge Funds Think About Dr. Reddy’s Laboratories Limited (RDY)
finance.yahoo.com - April 21 at 9:14 AM
Dr. Reddys to Release Q4 and Full Year FY 19 Results on May 17, 2019Dr. Reddy's to Release Q4 and Full Year FY 19 Results on May 17, 2019
finance.yahoo.com - April 17 at 6:34 PM
Dr. Reddys Laboratories Announces Acquisition of ANDA PortfolioDr. Reddy's Laboratories Announces Acquisition of ANDA Portfolio
finance.yahoo.com - April 13 at 5:15 PM
Is Indias 7.3% Growth Worth An Investment?Is India's 7.3% Growth Worth An Investment?
finance.yahoo.com - April 2 at 8:07 PM
Promius Pharma, LLC. (a Wholly Owned Subsidiary of Dr. Reddy’s Laboratories Ltd.) Announces the Sale and Assignment of the US Rights for Its Marketed Dermatology Brands to Encore DermatologyPromius Pharma, LLC. (a Wholly Owned Subsidiary of Dr. Reddy’s Laboratories Ltd.) Announces the Sale and Assignment of the US Rights for Its Marketed Dermatology Brands to Encore Dermatology
finance.yahoo.com - April 2 at 10:24 AM
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: volatile stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel